pI: 4.9459 |
Length (AA): 210 |
MW (Da): 22999 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 189 | 1txo (A) | 51 | 240 | 20.00 | 0 | 0.95 | 0.78 | 0.18 |
19 | 178 | 1a6q () | 96 | 305 | 13.00 | 0 | 0.23 | 0.61 | -0.2 |
16 | 152 | 2xzv (A) | 73 | 228 | 18.00 | 0 | 0.65 | 0.724381 | -0.32 |
20 | 187 | 2j82 (A) | 1079 | 1240 | 20.00 | 0 | 0.94 | 0.844 | 0.25 |
85 | 200 | 4e7n (A) | 120 | 245 | 34.00 | 0.96 | 0.31 | 0.538581 | 0.96 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127494)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G30170 | photosystem II core phosphatase |
Arabidopsis thaliana | AT4G16580 | putative protein phosphatase 2C |
Arabidopsis thaliana | AT5G66720 | putative protein phosphatase 2C 80 |
Brugia malayi | Bm1_20765 | 5-azacytidine resistance protein azr1 |
Candida albicans | CaO19.5661 | similar to S. cerevisiae YHR076W |
Candida albicans | CaO19.13106 | similar to S. cerevisiae YHR076W |
Caenorhabditis elegans | CELE_W09D10.4 | Protein W09D10.4 |
Cryptosporidium hominis | Chro.70512 | hypothetical protein |
Cryptosporidium parvum | cgd7_4640 | PP2C phosphatase |
Dictyostelium discoideum | DDB_G0280067 | protein phosphatase 2C-related protein |
Dictyostelium discoideum | DDB_G0288107 | protein phosphatase 2C-related protein |
Drosophila melanogaster | Dmel_CG7615 | fos intronic gene |
Drosophila melanogaster | Dmel_CG15035 | CG15035 gene product from transcript CG15035-RA |
Drosophila melanogaster | Dmel_CG12091 | CG12091 gene product from transcript CG12091-RB |
Echinococcus granulosus | EgrG_000815300 | protein phosphatase ptc7 |
Echinococcus multilocularis | EmuJ_000815300 | protein phosphatase ptc7 |
Homo sapiens | 160760 | PTC7 protein phosphatase homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.20.0660 | hypothetical protein, conserved |
Leishmania braziliensis | LbrM.25.1620 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_340770.1 | Stage II sporulation protein E (SpoIIE), putative |
Leishmania donovani | LdBPK_252140.1 | Stage II sporulation protein E (SpoIIE), putative |
Leishmania infantum | LinJ.25.2140 | hypothetical protein, conserved |
Leishmania infantum | LinJ.34.0770 | hypothetical protein, conserved |
Leishmania major | LmjF.34.0730 | hypothetical protein, conserved |
Leishmania major | LmjF.25.2060 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.33.0730 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.25.2060 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_03458 | 5-azacytidine resistance protein azr1 |
Mus musculus | ENSMUSG00000038582 | PTC7 protein phosphatase homolog (S. cerevisiae) |
Oryza sativa | 4334524 | Os03g0809300 |
Onchocerca volvulus | OVOC7807 | Protein phosphatase PTC7 homolog |
Plasmodium falciparum | PF3D7_1009600 | protein phosphatase, putative |
Plasmodium knowlesi | PKNH_0809300 | protein phosphatase, putative |
Plasmodium vivax | PVX_094695 | protein phosphatase 2C, putative |
Saccharomyces cerevisiae | YHR076W | type 2C protein phosphatase PTC7 |
Schistosoma japonicum | Sjp_0085700 | Protein phosphatase PTC7 homolog, putative |
Schistosoma mansoni | Smp_046890 | protein phosphatase 2C |
Schmidtea mediterranea | mk4.008191.02 | Protein phosphatase PTC7 homolog |
Trypanosoma brucei gambiense | Tbg972.4.3640 | protein phosphatase 2C, putative |
Trypanosoma brucei gambiense | Tbg972.3.2100 | protein phosphatase 2C, putative |
Trypanosoma brucei | Tb927.4.3680 | protein phosphatase 2C, putative |
Trypanosoma brucei | Tb927.3.2150 | protein phosphatase 2C, putative |
Trypanosoma congolense | TcIL3000_4_3180 | protein phosphatase 2C, putative |
Trypanosoma congolense | TcIL3000_3_1260 | protein phosphatase 2C, putative |
Trypanosoma cruzi | TcCLB.507081.50 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.506201.120 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.504129.40 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_347460 | protein phosphatase 2C, putative |
Trichomonas vaginalis | TVAG_158970 | protein phosphatase 2C, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.4.3680 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.3680 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.3680 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.4.3680 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.3.2150 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.2150 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.2150 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.2150 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.